JP2012092144A5 - - Google Patents

Download PDF

Info

Publication number
JP2012092144A5
JP2012092144A5 JP2012022511A JP2012022511A JP2012092144A5 JP 2012092144 A5 JP2012092144 A5 JP 2012092144A5 JP 2012022511 A JP2012022511 A JP 2012022511A JP 2012022511 A JP2012022511 A JP 2012022511A JP 2012092144 A5 JP2012092144 A5 JP 2012092144A5
Authority
JP
Japan
Prior art keywords
cell
test substance
psgl
cells
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012022511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012092144A (ja
Filing date
Publication date
Priority claimed from US10/051,497 external-priority patent/US7744888B2/en
Application filed filed Critical
Publication of JP2012092144A publication Critical patent/JP2012092144A/ja
Publication of JP2012092144A5 publication Critical patent/JP2012092144A5/ja
Pending legal-status Critical Current

Links

JP2012022511A 2001-08-03 2012-02-03 P−セレクチン糖タンパク質リガンド1のモジュレーター Pending JP2012092144A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31019601P 2001-08-03 2001-08-03
US60/310,196 2001-08-03
US10/051,497 US7744888B2 (en) 2001-08-03 2002-01-18 Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
US10/051,497 2002-01-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008058501A Division JP2008260759A (ja) 2001-08-03 2008-03-07 P−セレクチン糖タンパク質リガンド1のモジュレーター

Publications (2)

Publication Number Publication Date
JP2012092144A JP2012092144A (ja) 2012-05-17
JP2012092144A5 true JP2012092144A5 (https=) 2013-06-06

Family

ID=26729479

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003518607A Expired - Fee Related JP4815101B2 (ja) 2001-08-03 2002-03-13 P−セレクチン糖タンパク質リガンド1のモジュレーター
JP2008058501A Abandoned JP2008260759A (ja) 2001-08-03 2008-03-07 P−セレクチン糖タンパク質リガンド1のモジュレーター
JP2012022511A Pending JP2012092144A (ja) 2001-08-03 2012-02-03 P−セレクチン糖タンパク質リガンド1のモジュレーター

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2003518607A Expired - Fee Related JP4815101B2 (ja) 2001-08-03 2002-03-13 P−セレクチン糖タンパク質リガンド1のモジュレーター
JP2008058501A Abandoned JP2008260759A (ja) 2001-08-03 2008-03-07 P−セレクチン糖タンパク質リガンド1のモジュレーター

Country Status (19)

Country Link
US (3) US7744888B2 (https=)
EP (2) EP1411982B1 (https=)
JP (3) JP4815101B2 (https=)
KR (1) KR100850731B1 (https=)
CN (2) CN1304051C (https=)
AT (2) ATE411045T1 (https=)
AU (1) AU2002305041B2 (https=)
CA (1) CA2428822C (https=)
CY (2) CY1108701T1 (https=)
DE (1) DE60229394D1 (https=)
DK (2) DK1411982T3 (https=)
ES (2) ES2376948T3 (https=)
IL (4) IL160168A0 (https=)
MX (1) MXPA04001047A (https=)
NO (2) NO333456B1 (https=)
NZ (1) NZ531199A (https=)
PT (2) PT1411982E (https=)
TW (1) TWI327070B (https=)
WO (1) WO2003013603A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040116333A1 (en) 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
CA2538284C (en) * 2003-09-15 2015-10-20 Rong-Hwa Lin Modulators of p-selectin glycoprotein ligand 1
WO2005047320A2 (en) * 2003-11-12 2005-05-26 Wisconsin Alumni Research Foundation Equine p-selection glycoprotein ligand-1 and uses thereof
MY148646A (en) * 2004-05-10 2013-05-15 Abgenomics Cooperatief Ua Anti-psgl-1 antibodies
AU2012201999C1 (en) * 2004-05-10 2016-05-12 Abgenomics Cooperatief U.A. Antibodies
CN1985000B (zh) * 2004-05-11 2012-05-30 艾比吉诺米克斯合作公司 诱导t细胞死亡的表位
WO2007033959A2 (en) * 2005-09-19 2007-03-29 Vib Vzw Use of p-selectin glycoprotein ligand 1 in modulation of hematogenous metastasis of lymphomas
WO2007067984A2 (en) * 2005-12-09 2007-06-14 Wyeth Neutralizing antibodies against primate psgl-1 and uses therefor
WO2009140623A2 (en) * 2008-05-15 2009-11-19 Selexys Pharmaceuticals Corporation Anti-psgl-1 antibodies and methods of identification and use
ES2387156B1 (es) * 2010-12-01 2013-07-04 Universidad Autónoma de Madrid Uso de psgl-1 para el tratamiento de enfermedades inflamatorias y autoinmunes
MX358447B (es) 2011-06-13 2018-08-21 Abgenomics Cooeperatief U A Star Anticuerpos anti-psgl-1 y usos de los mismos.
PT3166636T (pt) * 2014-07-08 2021-06-29 Sanford Burnham Med Res Inst Moduladores de psgl-1 e utilizações dos mesmos
SG11201805557SA (en) 2016-01-08 2018-07-30 Bioalliance Cv Tetravalent anti-psgl-1 antibodies and uses thereof
US20170241415A1 (en) * 2016-02-19 2017-08-24 Muzan, Inc. Sanitary check valve
EP3568159A4 (en) 2017-01-11 2020-08-05 Bristol-Myers Squibb Company PSGL-1 ANTAGONISTS AND THEIR USES
KR102715540B1 (ko) 2017-03-14 2024-10-08 파이브 프라임 테라퓨틱스, 인크. 산성 pH에서 VISTA에 결합하는 항체
BR112020019083A2 (pt) 2018-03-21 2020-12-29 Five Prime Therapeutics, Inc. Anticorpos, ácido nucleico, composições, célula e métodos para preparar um anticorpo, para tratar câncer, para tratar uma doença infecciosa, para tratar uma inflamação, para a identificação de um anticorpo, para melhorar a eficácia antitumoral de um anticorpo, para melhorar a farmacocinética de um anticorpo, para selecionar um anticorpo, para melhorar a eficácia de anticorpos, para isolar anticorpos, para detectar vista em uma amostra e para tratar câncer
BR112021000303A2 (pt) 2018-07-11 2021-04-13 Five Prime Therapeutics, Inc. Anticorpos que se ligam a vista em ph ácido
KR102767692B1 (ko) 2018-07-20 2025-02-17 피에르 파브르 메디카먼트 Vista의 수용체
WO2020224450A1 (en) * 2019-05-03 2020-11-12 The University Of Hong Kong Method for peritoneal metastatic cell detection and isolation thereof
CA3141334A1 (en) * 2019-06-04 2020-12-10 Verseau Therapeutics, Inc. Anti-psgl-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof
WO2025168211A1 (en) * 2023-02-10 2025-08-14 Novo Nordisk A/S P-selectin peptide ligands

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5378464A (en) 1989-03-08 1995-01-03 Board Of Regents Of The University Of Oklahoma Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140
US5464778A (en) 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US5690933A (en) * 1989-05-31 1997-11-25 Glaxo Wellcome Inc. Monoclonal antibodies for inducing tolerance
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ATE300615T1 (de) 1990-08-29 2005-08-15 Genpharm Int Transgene mäuse fähig zur produktion heterologer antikörper
US5709859A (en) 1991-01-24 1998-01-20 Bristol-Myers Squibb Company Mixed specificity fusion proteins
US6124267A (en) 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US6309639B1 (en) 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US5972625A (en) 1991-05-06 1999-10-26 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5843707A (en) 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
WO1994014836A1 (en) 1992-12-18 1994-07-07 Centocor, Inc. Peptide inhibitors of selectin binding
NZ261991A (en) 1993-01-25 1998-04-27 Dana Farber Cancer Inst Inc Chimeric l and p selectin made by exchange of domains, uses thereof
WO1995014787A1 (en) 1993-11-22 1995-06-01 Centocor, Inc. Peptide inhibitors of selecting binding
US5686426A (en) * 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
EP0850243B1 (en) 1995-08-03 2003-10-08 Board Of Regents Of The University Of Oklahoma o-glycan inhibitors of selectin mediated inflammation
JPH09227410A (ja) 1996-02-21 1997-09-02 Sumitomo Pharmaceut Co Ltd 臓器移植拒絶反応の抑制剤
WO1999043353A2 (en) 1998-02-26 1999-09-02 Boehringer Ingelheim Pharmaceuticals, Inc. Combination anti-selectin and immunosuppressant therapy
MXPA01004310A (es) 1998-10-30 2003-06-06 Cbr Lab Inc Inhibicion de diferenciacion de celulas t citotoxicas mediante antagonistas de ligando de p-selectina (psgl).
US20040001839A1 (en) 2000-12-29 2004-01-01 Avigdor Levanon Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040002450A1 (en) * 2000-12-29 2004-01-01 Janette Lazarovits Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
CA2433225A1 (en) 2000-12-29 2002-07-11 Bio-Technology General, Inc. Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US7744888B2 (en) 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
US20040116333A1 (en) 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US20050152906A1 (en) * 2003-06-30 2005-07-14 Avigdor Levanon Specific human antibodies
MY148646A (en) 2004-05-10 2013-05-15 Abgenomics Cooperatief Ua Anti-psgl-1 antibodies
CN1985000B (zh) 2004-05-11 2012-05-30 艾比吉诺米克斯合作公司 诱导t细胞死亡的表位
MX358447B (es) 2011-06-13 2018-08-21 Abgenomics Cooeperatief U A Star Anticuerpos anti-psgl-1 y usos de los mismos.

Similar Documents

Publication Publication Date Title
JP2012092144A5 (https=)
MX362075B (es) Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
WO2014015194A3 (en) Methods for detecting and measuring aggregation
MX389472B (es) Inmunoensayo que utiliza un conjugado de captura
MX2017005750A (es) Ensayos para detectar subgrupos inmunes de células t y sus métodos de uso.
WO2019105468A8 (en) Methods for using cd137 ligand as a biomarker for treatment with anti-cd137 antibody
EP2801092A4 (en) METHODS, DEVICES AND COMPUTER PROGRAM PRODUCTS FOR IMPLEMENTING AUTOMATIC LANGUAGE RECOGNITION AND RECEIVING RECOGNITION ON A DEVICE
JP2016511405A5 (https=)
EP2972348A4 (en) METHOD FOR DETECTING DONATOR-SPECIFIC ANTIBODIES AND SYSTEMS FOR CARRYING OUT THEREOF
TR201904882T4 (tr) Tıbbi kullanım için bispesifik antikorlar.
MX2016005686A (es) Ensayo de union competitiva al ligando para detectar anticuerpos neutralizantes.
AU2011285694A8 (en) Detection of degradation products of canine NT-proBNP
PH12016501339B1 (en) Novel anti-netrin-1 antibody
WO2013165972A3 (en) Anti-hepatitis b virus antibodies and use thereof
JP2015520378A5 (https=)
WO2015003160A3 (en) Hepatocytes in co-culture and uses thereof
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение
WO2014025424A3 (en) Boron-nitrogen-containing acene compounds and their preparation
EP2546266A4 (en) MONOCLONAL ANTIBODY AGAINST THE NEKROSEMARKER ERP29 AND USE THEREOF
SG11201700407QA (en) Frame member-equipped transfer film, biomolecule analysis device, reagent tank, and shaking device
FR2996010B1 (fr) Dispositif de prediction des seismes et des eruptions volcaniques, de localisation des epicentres et des magnitudes par la mesure du radon dans le sol
WO2018176030A3 (en) Antibodies and immunoassays for detection of bmp-15 and gdf-9 isoforms
WO2012158207A3 (en) Method for mutiplexed microfluidic bead-based immunoassay
WO2015069718A3 (en) Pre-haptoglobin-2 monoclonal antibodies and uses thereof
王腾 et al. Influence of two typhoon events on the content and flux of nutrient and organic carbon in the upper Minjiang Estuary